BioNeutra Global

BioNeutra Global Financial Leverage

The Financial Leverage (Equity Multiplier) of BioNeutra Global (BGA.V) as of Oct 26, 2026 is -2.55. In the previous year, Financial Leverage (Equity Multiplier) was -5.27 — a change of -51.67% (higher).

Financial Leverage

-2.55

YoY

-51.67%

Last updated:

Financial Leverage (Equity Multiplier) of BioNeutra Global is 2023 -2.55 . Financial Leverage (Equity Multiplier) of BioNeutra Global was 2022 -5.27 . It decreases by -51.67% higher compared to the previous year.

The BioNeutra Global Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2016
2.32 CAD
Jan 1, 2017
2.22 CAD
Jan 1, 2018
2.21 CAD
Jan 1, 2019
7.16 CAD
Jan 1, 2020
33.78 CAD
Jan 1, 2021
-20.39 CAD
Jan 1, 2022
-5.27 CAD
Jan 1, 2023
-2.55 CAD
The BioNeutra Global Financial Leverage history
YEARFinancial LeverageYoY
-2.55-51.67%
-5.27-74.17%
-20.39-160.37%
33.78+371.85%
7.16+223.33%
2.21-0.22%
2.22-4.30%
2.32+31.50%
1.76+35.69%
1.30—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioNeutra Global Stock analysis

What does BioNeutra Global do? BioNeutra Global Corp generates revenue through the research, development, production, and commercialization of nutraceutical, functional, and mainstream food and beverage ingredients. Its lead product, VitaFiber IMO, is a natural, low-calorie, soluble prebiotic fiber derived from agricultural crops like tapioca, field pea, or corn. The company sells VitaFiber IMO to small and medium enterprises and food manufacturers for incorporation into their products. Additionally, VitaFiber IMO is available for retail purchase via Amazon.com and Shopify.com, allowing direct consumer sales. VitaFiber IMO is produced using patented processes that transform starch molecules into isomalto-oligosaccharide (IMO), offering a naturally sweet alternative to sugar with digestive health benefits. The product targets health-conscious consumers seeking low-calorie, functional food ingredients, appealing to both manufacturers and end-users through its retail presence on global e-commerce platforms. BioNeutra's commercial model combines B2B sales to food manufacturers with direct-to-consumer retail on Amazon.com and Shopify.com, leveraging its patented technology to create a dual revenue stream. The company focuses on natural, health-oriented ingredients that align with growing market demands for functional foods and beverages. BioNeutra Global is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioNeutra Global stock

Financial Leverage (Equity Multiplier) of BioNeutra Global is -2.55 in 2023.

Financial Leverage (Equity Multiplier) of BioNeutra Global changed from -5.27 to -2.55, representing a -51.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) BioNeutra Global since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s BioNeutra Global with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — BioNeutra Global

All Key Metrics — BioNeutra Global